This is very much linked back to the cost of the drugs as well, given that there is already a lot of concern over maintaining job security and a stable paycheque in this economic climate, Houliston added
This comprehensive guide is designed to demystify the FDA Category 2 peptide changes coming in 2026, focusing on what these updates mean for patients currently utilizing or considering therapies involving BPC-157, TB-500, KPV, MOTs-c, and GHK-Cu
(NYSE:LLY) announced that the highest approved doses of Zepbound (tirzepatide), 12.5 mg and 15 mg, would soon be available in single-dose vials for $499 per month through LillyDirect's Self Pay Pharmacy Solutions and the Zepbound Self Pay Journey Program
For instance, the concurrent use of hypoglycemic medications may heighten the risk of hypoglycemia
THIRD-PARTY DATA The company tests all its products using independent third-party certified laboratories to verify the percentage of drug permeation at specific time intervals